MCDERMOTT+ LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Prescription drug pricing issues. Implementation of the Inflation Reduction Act - Public Law No 117-69. H.R. 485 - the Protecting Health Care for All Patients Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
Pharmacy PHA
Prescription drug pricing issues. Pricing of Covid 19 vaccines. H.R. 485 - the Protecting Health Care for All Patients Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
Copyright/Patent/Trademark CPT
Patent abuse issues. Affordable Prescriptions for Patients Act of 2023. Interagency Patent Coordination Act. Initiatives To Ensure the Robustness and Reliability of Patents Rights (PTO-P-2022-0025). Joint USPTO-FDA Collaboration Initiatives. Notice of Public Listening Session and Request for Comment (PTO-P-2022-0037).
| Lobbyist | Covered position, as disclosed |
|---|---|
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.